Keyphrases
Human Immunodeficiency Virus Type 1 (HIV-1)
100%
Virus Replication
100%
Rhesus
100%
Simian Immunodeficiency Virus
100%
(I)-envelope
100%
Envelope Glycoprotein
56%
Rhesus Macaque
31%
Lymphocytes
25%
Viral Entry
25%
Env Conformation
25%
Conformational States
18%
Membrane Fusion
12%
Challenge Virus
12%
Single Amino Acid Substitution
12%
Viral Host
12%
Clinically Significant
6%
Preclinical Testing
6%
Neutralizing Antibodies
6%
Vaccine Development
6%
Biologically Relevant
6%
Pullout
6%
Obligate
6%
Vaccine Approaches
6%
Preferred Models
6%
Physiological Level
6%
Closed Conformation
6%
Major Determinants
6%
Genetic Evidence
6%
Open Conformation
6%
Soluble CD4
6%
Viral Fusion
6%
Entry Barriers
6%
New Infections
6%
CD4 Receptor
6%
CD4 Binding
6%
Transmitted Founder
6%
BG505
6%
Prevention Approaches
6%
Fusogenicity
6%
Immunology and Microbiology
Human Immunodeficiency Virus 1
100%
Viral Replication
100%
Human Immunodeficiency Virus
100%
Conformation
100%
CD4
100%
Glycoprotein
56%
Rhesus Monkey
31%
Viral Entry
25%
Lymphocyte
25%
Membrane Fusion
12%
Amino Acid Substitution
12%
Neutralizing Antibody
6%
Fusogenicity
6%